Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Tinnitus Implant System for the Treatment of Chronic Severe Tinnitus: An Early Feasibility Study

NCT03988699 is registered in ClinicalTrials.gov with Matthew L. Carlson, M.D. as lead sponsor.

NCT NCT03988699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03988699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Tinnitus Implant System for the Treatment of Chronic Severe Tinnitus: An Early Feasibility Study
Lead sponsor
Matthew L. Carlson, M.D.
Phase
Not applicable
Overall status
Completed
Start date
August 23, 2021
Completion date
September 10, 2024
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tinnitus